Lates News

Every AI Express Investment News, Huayuan Securities released a research report on April 4th giving a "buy" rating to WuXi AppTec (603259.SH). The reasons for the rating include: 1) WuXi AppTec provides integrated end-to-end drug research and production services for the global pharmaceutical and life sciences industry; 2) The TIDES business maintains rapid growth, D&M is expected to increase in volume, and the safety evaluation business maintains a leading position in the Asia-Pacific region; 3) Orders continue to grow, capacity construction is advancing, and the company's future performance is expected to be stable or resilient. (Daily Economic News)